Related Experiment Video
Updated: Jul 12, 2026

Contractility Measurements on Isolated Papillary Muscles for the Investigation of Cardiac Inotropy in Mice
Published on: September 17, 2015
Muscarinic receptor modulation of basal and beta-adrenergic stimulated function of the failing human left ventricle
G E Newton1, A B Parker, J S Landzberg
1Cardiovascular Division, Department of Medicine, Mount Sinai Hospital, the University of Toronto, Ontario, Canada.
Abstract:
The objective of this study was to evaluate the effect of muscarinic receptor modulation on basal and beta-adrenergic stimulated left ventricular function in patients with heart failure. 21 heart failure patients and 14 subjects with normal ventricular function were studied. In Protocol 1 intracoronary acetylcholine resulted in a 60+/-8% inhibition of the left ventricular +dP/dt response to intracoronary dobutamine in the normal group, and a similar 70+/-13% inhibition in the heart failure group. Acetylcholine also attenuated the dobutamine-mediated acceleration of isovolumic relaxation (Tau) in both groups. Acetylcholine alone had no effect on Tau in the normal group, while it prolonged Tau in the heart failure group. In Protocol 2 intracoronary atropine resulted in a 35+/-10% augmentation of the inotropic response to dobutamine in the normal group, versus a non-significant 12+/-15% augmentation of the dobutamine response in the heart failure group. In Protocol 3, in 6 heart failure patients, both effects of acetylcholine, the slowing of ventricular relaxation and the inhibition of beta-adrenergic responses, were reversed by the addition of atropine. Therefore, in the failing human left ventricle muscarinic stimulation has an independent negative lusitropic effect and antagonizes the effects of beta-adrenergic stimulation.
Insights
Muscarinic receptor stimulation negatively impacts heart failure by slowing relaxation and reducing beta-adrenergic responses. This study reveals key insights into cardiac function modulation in heart failure patients.
Area of Science:
- Cardiology
- Pharmacology
- Physiology
Background:
- Heart failure is characterized by impaired left ventricular function.
- Beta-adrenergic stimulation typically enhances contractility but can be less effective in heart failure.
- The role of muscarinic receptors in modulating cardiac function during heart failure requires further elucidation.
Purpose of the Study:
- To investigate the impact of muscarinic receptor modulation on left ventricular function.
- To assess the interaction between muscarinic and beta-adrenergic pathways in normal and failing hearts.
- To determine the specific effects of acetylcholine and atropine on cardiac contractility and relaxation.
Main Methods:
- Intracoronary administration of acetylcholine and atropine in patients with heart failure and healthy controls.
- Measurement of left ventricular +dP/dt (contractility) and isovolumic relaxation time (Tau).
- Evaluation of responses to dobutamine (a beta-adrenergic agonist) alone and in combination with muscarinic agents.
Main Results:
- Acetylcholine inhibited dobutamine-induced contractility in both normal and heart failure groups.
- Acetylcholine prolonged isovolumic relaxation time (negative lusitropic effect) in heart failure patients.
- Atropine partially reversed acetylcholine's effects, indicating muscarinic receptor involvement.
Conclusions:
- Muscarinic receptor stimulation exerts an independent negative lusitropic effect on the failing human left ventricle.
- Muscarinic stimulation antagonizes the beneficial effects of beta-adrenergic stimulation in heart failure.
- Targeting muscarinic pathways may offer novel therapeutic strategies for heart failure management.
Related Concept Videos
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Pathophysiology of Heart Failure
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure Drugs: β-Blockers
Mitral Regurgitation I: Introduction
Heart Failure II: Pathophysiology

